Skip to main content

Table 5 Quality of life according to demographic and clinical factors on (multivariate analysis)

From: Quality of life during chemotherapy, hormonotherapy or antiHER2 therapy of patients with advanced, metastatic breast cancer in clinical practice

Variable

Risk ratio (95%Cl)

p

ECOG performance status

1,35 (1,15-1,55)

0,01

Target therapy addition

0,91 (0,75-1,07)

0,19

Age

1,03 (0,90-1,16)

0,22

Education

1,05 (0,90-1,20)

0,37

Smoking status

0,95 (0,88-1,03)

0,09

Response to treatment

0,78 (0,68-0,88)

< 0,01

Chemotherapy/hormone therapy

1,20 (1,10-1,31)

< 0,01